Anticoagulant and antithrombotic evaluation of native fucosylated chondroitin sulfates and their derivatives as selective inhibitors of intrinsic factor Xase
Wu, Mingyi1; Wen, Dandan1,2; Gao, Na1; Xiao, Chuang1,3; Yang, Lian1; Xu, Li1; Lian, Wu1,3; Peng, Wenlie3; Jiang, Jianmin2; Zhao, Jinhua1
刊名EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2015-03-06
卷号92页码:257-269
关键词Fucosylated chondroitin sulfate Factor Xase inhibitor Anticoagulant Antithrombotic Structure-activity relationship
通讯作者Jiang,JM (reprint author),Sun Yat Sen Univ,Sch Pharmaceut Sci,Guangzhou 510006,Guangdong,Peoples R China. ; lssjjm@mail.sysu.edu.cn ; zhao.jinhua@yahoo.com
英文摘要Fucosylated chondroitin sulfate (FCS), a structurally unusual glycosaminoglycan, has distinct anticoagulant properties, and is an especially strong inhibitor of the intrinsic factor Xase (anti-Xase). To obtain a highly selective inhibitor of human Xase, we purified six native FCSs with various sulfation patterns, prepared a series of FCS derivatives, and then elucidated the relationship between the structures and the anticoagulant activities of FCSs. FCSs 1-3 containing higher Fuc2S4S exhibit stronger AT-dependent anti-IIa activities, whereas 4-6 containing more Fuc3S4S produce potent HCII-dependent anti-IIa activities. Saccharides containing a minimum of 6-8 trisaccharide units, free carboxyl groups, and full fucosylation of GlcA may be required for potent anti-Xase activity, and approximately six trisaccharide units and partial fucosylation of GlcA may contribute to potent HCII-dependent activity. Decreasing of the molecular weights markedly reduces their AT-dependent anti-IIa activities, and even eliminates human platelet and factor XII activation. Furthermore, in vitro and in vivo studies suggested that fractions of 6-12 kDa may be very promising compounds as putative selective intrinsic Xase inhibitors with antithrombotic action, but without the consequences of major bleeding and factor XII activation. (C) 2014 Elsevier Masson SAS. All rights reserved.
学科主题Chemistry, Medicinal
类目[WOS]Chemistry, Medicinal
研究领域[WOS]Pharmacology & Pharmacy
关键词[WOS]DEPOLYMERIZED HOLOTHURIAN GLYCOSAMINOGLYCAN ; STICHOPUS-JAPONICUS SELENKA ; MOLECULAR-WEIGHT HEPARINS ; SEA-CUCUMBER ; FACTOR-IXA ; PHYSICOCHEMICAL CHARACTERISTICS ; POLYSACCHARIDE ACCOUNT ; BLOOD PLATELETS ; FUCOSE BRANCHES ; THROMBIN
收录类别SCI
语种英语
WOS记录号WOS:000350919100020
内容类型期刊论文
源URL[http://ir.kib.ac.cn/handle/151853/20615]  
专题昆明植物研究所_植物化学与西部植物资源持续利用国家重点实验室
作者单位1.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Peoples R China
2.Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China
3.Sun Yat Sen Univ, Coll Life Sci, Guangzhou 510006, Guangdong, Peoples R China
推荐引用方式
GB/T 7714
Wu, Mingyi,Wen, Dandan,Gao, Na,et al. Anticoagulant and antithrombotic evaluation of native fucosylated chondroitin sulfates and their derivatives as selective inhibitors of intrinsic factor Xase[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2015,92:257-269.
APA Wu, Mingyi.,Wen, Dandan.,Gao, Na.,Xiao, Chuang.,Yang, Lian.,...&Zhao, Jinhua.(2015).Anticoagulant and antithrombotic evaluation of native fucosylated chondroitin sulfates and their derivatives as selective inhibitors of intrinsic factor Xase.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,92,257-269.
MLA Wu, Mingyi,et al."Anticoagulant and antithrombotic evaluation of native fucosylated chondroitin sulfates and their derivatives as selective inhibitors of intrinsic factor Xase".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 92(2015):257-269.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace